Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Southern Europe

Southern Europe

Southern Europe is projected to experience significant growth in the Treatment of Cardiovascular Diseases market.
The revenue in this market segment is expected to reach US$22.22bn by 2024.
Furthermore, a steady annual growth rate of 2.89% (CAGR 2024-2029) is anticipated, which will result in a market volume of US$25.62bn by 2029.
When compared globally, in the United States is forecasted to generate the highest revenue in the Treatment of Cardiovascular Diseases market, with a projected revenue of US$136.00bn in 2024.
In Southern Europe, Spain is leading the way in the development and implementation of innovative treatments for cardiovascular diseases.

Key regions: China, India, United States, France, Canada

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.